Akshay G. Patel, MS, MD, PhD
Hospital ResidentCards
About
Research
Publications
2025
Potassium-Hydroxide-Based Extraction of Nicotinamide Adenine Dinucleotides from Biological Samples Offers Accurate Assessment of Intracellular Redox Status
Faludi T, Krakko D, Nolan J, Hanczko R, Patel A, Oaks Z, Ruggiero E, Lewis J, Wang X, Huang T, Molnar-Perl I, Perl A. Potassium-Hydroxide-Based Extraction of Nicotinamide Adenine Dinucleotides from Biological Samples Offers Accurate Assessment of Intracellular Redox Status. International Journal Of Molecular Sciences 2025, 26: 10371. PMID: 41226410, PMCID: PMC12607542, DOI: 10.3390/ijms262110371.Peer-Reviewed Original Research
2024
Redox Pathogenesis in Rheumatic Diseases
Laniak O, Winans T, Patel A, Park J, Perl A. Redox Pathogenesis in Rheumatic Diseases. ACR Open Rheumatology 2024, 6: 334-346. PMID: 38664977, PMCID: PMC11168917, DOI: 10.1002/acr2.11668.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsRab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation
Huang N, Winans T, Wyman B, Oaks Z, Faludi T, Choudhary G, Lai Z, Lewis J, Beckford M, Duarte M, Krakko D, Patel A, Park J, Caza T, Sadeghzadeh M, Morel L, Haas M, Middleton F, Banki K, Perl A. Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation. Nature Communications 2024, 15: 2598. PMID: 38519468, PMCID: PMC10960037, DOI: 10.1038/s41467-024-46441-2.Peer-Reviewed Original Research
2023
mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency
Winans T, Oaks Z, Choudhary G, Patel A, Huang N, Faludi T, Krakko D, Nolan J, Lewis J, Blair S, Lai Z, Landas S, Middleton F, Asara J, Chung S, Wyman B, Azadi P, Banki K, Perl A. mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency. Journal Of Autoimmunity 2023, 140: 103112. PMID: 37742509, PMCID: PMC10957505, DOI: 10.1016/j.jaut.2023.103112.Peer-Reviewed Original ResearchPublisher Correction: Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis
Oaks Z, Patel A, Huang N, Choudhary G, Winans T, Faludi T, Krakko D, Duarte M, Lewis J, Beckford M, Blair S, Kelly R, Landas S, Middleton F, Asara J, Chung S, Fernandez D, Banki K, Perl A. Publisher Correction: Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis. Nature Metabolism 2023, 5: 349-349. PMID: 36755183, DOI: 10.1038/s42255-023-00752-8.Commentaries, Editorials and LettersLy-6A-Induced Growth Inhibition and Cell Death in a Transformed CD4+ T Cell Line: Role of Tumor Necrosis Factor-α
Patel A, Moxham S, Bamezai A. Ly-6A-Induced Growth Inhibition and Cell Death in a Transformed CD4+ T Cell Line: Role of Tumor Necrosis Factor-α. Archivum Immunologiae Et Therapiae Experimentalis 2023, 71: 4. PMID: 36725744, DOI: 10.1007/s00005-023-00670-3.Peer-Reviewed Original ResearchCytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis
Oaks Z, Patel A, Huang N, Choudhary G, Winans T, Faludi T, Krakko D, Duarte M, Lewis J, Beckford M, Blair S, Kelly R, Landas S, Middleton F, Asara J, Chung S, Fernandez D, Banki K, Perl A. Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis. Nature Metabolism 2023, 5: 41-60. PMID: 36658399, PMCID: PMC9892301, DOI: 10.1038/s42255-022-00711-9.Peer-Reviewed Original Research
2022
Redox Control of Integrin-Mediated Hepatic Inflammation in Systemic Autoimmunity
Patel A, Perl A. Redox Control of Integrin-Mediated Hepatic Inflammation in Systemic Autoimmunity. Antioxidants & Redox Signaling 2022, 36: 367-388. PMID: 34036799, PMCID: PMC8982133, DOI: 10.1089/ars.2021.0068.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2017
Engaging Ly‐6A/Sca‐1 triggers lipid raft‐dependent and ‐independent responses in CD4+ T‐cell lines
Lang M, Jenkins S, Balzano P, Owoyele A, Patel A, Bamezai A. Engaging Ly‐6A/Sca‐1 triggers lipid raft‐dependent and ‐independent responses in CD4+ T‐cell lines. Immunity Inflammation And Disease 2017, 5: 448-460. PMID: 28660664, PMCID: PMC5691314, DOI: 10.1002/iid3.182.Peer-Reviewed Original Research